Medtronic Meets Q1 Forecasts With Higher Profit

The company said sales to emerging markets continue to lag goals

   

Medtronic Meets Q1 Forecasts With Higher Profit

Medtronic (NYSE:MDT) announced on Tuesday that it earned $864 million during its fiscal first quarter, up from $827 million in the same period last year.

The medical device maker posted quarterly revenue of $4.01 billion, up from $3.95 billion in 2011.

caduceus 200x200 Medtronic Meets Q1 Forecasts With Higher Profit
6 Medical Devices Stocks to Sell Now

Adjusted EPS for the quarter was 85 cents. That was in line with Wall Street predictions, Reuters noted.

Shares of Medtronic remained flat in Tuesday morning trading.

Company officials reiterated their previously issued forecast for fiscal 2013 earnings of between $3.62 and $3.70 a share, saying they wanted to remain “very conservative” in their projections.

The company noted a 5% drop in sales of its cardiac rhythm management devices, including defibrillators and pacemakers. This was attributed to a greater reliance on existing device inventories by hospitals. That decline was offset by a 5% rise in sales of products like stents and heart valves at its surgical technology unit.

Sales in developing countries continue to lag company targets, amounting to just 11% of total sales, well behind plans to boost that to 20%.


Article printed from InvestorPlace Media, http://investorplace.com/2012/08/medtronic-meets-q1-forecasts-with-higher-profit/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.